In another study, treatment of c-MYC-expressing myeloma cells with the 10058-F4 compound, an inhibitor of MYC-MAX heterodimerization, resulted in rapid apoptosis, suggesting that there is an addiction to c-MYC for survival in these cancer cells [48]. This evidence concerns the gene MAX and plasma cell myeloma.